
The HIV & STI Collaborative
About Us
The HIV and STI Collaborative is a collaboration between the divisions of Pediatrics and Adult Infectious Diseases (ID) at Rutgers Robert Wood Johnson Medical School. Both divisions have had a long-standing collaboration, with the Robert Wood Johnson AIDS Program (RWJAP) being an integral part of the clinical services and providing robust, comprehensive, multidisciplinary, culturally diverse and family-centered HIV care services through the Ryan White HIV/AIDS Program. Since its inception in 1988. RWJAP has grown over the years to include HIV prevention services through New Jersey Department of Health (NJDOH) funded programs for free HIV testing and pre-exposure prophylaxis (PrEP). This expansion extended to Adult ID as the client base for individuals needing PrEP grew and increased the need for a more integrated approach to HIV services. This project utilizes the status neutral model of care approach, a framework that provides HIV services to everyone, regardless of their HIV status.
ID physicians and support staff in both divisions use an up-to-date evidence-based approach for treating patients and have many years of experience in treating persons living with HIV infection and AIDS (PLWHA). This project is composed of a multidisciplinary team including physicians, psychologist, program coordinator, a nurse case manager, family case manager, PrEP counselor, HIV counselor and a program assistant.
Our Services
HIV and STI Prevention
-
Free, confidential, rapid HIV screening is available by appointment at 89 French St. New Brunswick, regardless of insurance status. The screening tool used is the Determine HIV-1/2 Ag/Ab Combo, a 4th generation test which detects both HIV antibodies and antigens as early as 14 days after exposure. The screening consists of obtaining whole blood sample from a finger prick, and results are obtained in 20 minutes. Note that if a test is performed within the HYPERLINK "https://www.hiv.gov/hiv-basics/hiv-testing/learn-about-hiv-testing/hiv-testing-overview"window period we may not be able to give you a conclusive result. If you have had a possible exposure within the past 72 hours, contact us to discuss your options and to schedule an appointment for baseline screening. (see the section on nPEP)
For all other STI screenings, including syphilis, gonorrhea and chlamydia, based on insurance status, patients will be seen at the ID clinics, while uninsured or underinsured patients, will be referred to Eric B. Chandler Health Center or the Middlesex County Public Health Clinic (STD Clinic).
-
PrEP is the most common and most effective biomedical HIV prevention option available, with effectiveness around 99% for sexual exposures when taken as directed before exposure. It is commonly prescribed as a daily oral pill and can also be given as an injection every month or every other month in some cases. Oral PrEP is available regardless of insurance status, and all insurance plans must cover at least one form of PrEP. This is a good option for anyone who wants ongoing HIV protection for any reason. For more information on PrEP, visit the CDC website.
-
nPEP is a protocol to prevent HIV after a possible exposure that isn’t related to work, such as a broken condom or sexual assault. nPEP must be started within 72 hours of possible exposure (some exceptions may apply) and consists of 2 or 3 pills taken daily for 28 days. Unlike PrEP, nPEP is only taken for one month to effectively prevent acquisition of HIV after exposure. After completion of nPEP, patients can start PrEP if so desired. If the exposure occurs outside of business hours, many emergency departments provide nPEP, and patients can connect with us for guidance and follow-up. For more information about nPEP, visit the CDC website.
-
PIP is an emerging alternative to PrEP for HIV prevention, recently encouraged by the World Health Organization in certain situations. Whereas PrEP needs to be taken as a daily pill, monthly or bi-monthly injections, and nPEP is generally given in emergency circumstances, PIP gives patients the flexibility to take nPEP as needed, without having to rush for emergency care. This option can be fitting for patients who only have occasional, infrequent exposures, and who aren’t interested in taking regular PrEP. PIP can be given multiple times, and PIP users can remain engaged in ongoing care with our team.
-
DoxyPEP is a new form of prevention strategy for STIs other than HIV endorsed by CDC in summer 2024 to help prevent bacterial STIs, specifically syphilis, chlamydia, and to a lesser extent, gonorrhea. It involves taking a single dose of an antibiotic called doxycycline within 72 hours of possible exposure. DoxyPEP is an emergency measure and cannot be taken daily. If the exposure occurs outside of business hours, some emergency departments provide DoxyPEP, and patients can connect with us for guidance and follow-up. For more information about doxyPEP, please visit the CDC website.
Clinical Management of HIV/AIDS
Treatment for HIV/AIDS is known as antiretroviral therapy (ART). There is no cure for HIV/AIDS but there several medications available that are well tolerated and allow people living with HIV to live healthy, normal lives. There are currently two treatment options - pills and injections. Our doctors will meet with you to discuss the best option and create an individualized treatment plan for you. Read more about HIV treatment at: Treating HIV | HIV | CDC and HIV Treatment: The Basics | NIH. It is important to screen for HIV routinely so that anyone who is infected can start treatment immediately
Ryan White Case Management
Medical Case management is a client-centered approach that facilitates the linkage and coordination of health and psychosocial services for eligible clients, including but not limited to, follow-up of medical treatments, treatment adherence counseling to ensure readiness for, and adherence to, complex HIV/AIDS treatments. The nurse and family case managers will work together with the physicians to assess needs and develop a comprehensive care plan, coordinate services required to implement the plan and monitor efficacy of the plan. Patients are re-valuated periodically for updates and necessary amendments of the plan. This also ensures that patients receive access to medically appropriate healthcare and support services in a timely manner to maintain continuity of care. Case management services are available in accordance with the Ryan White Program Available Care and Services | Ryan White HIV/AIDS Program
General Infectious Diseases Conditions
Our specialists in infectious diseases provide a full range of consultative services for people with infections. These conditions include, but are not limited to, post-surgical infections, infections in transplant and other immunocompromised patients, and infections of the bones, joints, lungs and intestines. In addition, we manage and treat individuals who are co-infected with HIV and chronic hepatitis B and C.
Our Faculty

Patricia N. Whitley-Williams, MD, FAAP
Senior Associate Dean for Equity and Inclusion, Professor of Pediatrics, and Chief, Division of Allergy, Immunology and Infectious Diseases
Phone732-235-7894
Emailwhitlepn@rutgers.edu
Pediatric Infectious Diseases

Amisha Malhotra, MD
Associate Professor and Assistant Dean for Infectious Disease and Infection Control
Phone732-235-7894
Emailmalhotam@rutgers.edu
Pediatric Infectious Diseases

Gail Burack, PhD
Assistant Professor
Areas of ExpertiseChild Psychology, Developmental Disabilities, Chronic Illness
Phone(732) 235-7894
Pediatric Infectious Diseases



Tanaya Bhowmick, MD
Associate Professor, Program Director, Infectious Diseases Fellowship, and Chair, Antimicrobial Stewardship Program, RWJUH
Adult Infectious Diseases


Susan Boruchoff, MD
Adult Infectious Diseases


Ahmed Abdul Azim, MD
Assistant Professor and Associate Chair, Antimicrobial Stewardship Program, RWJUH
Emailaa2270@rutgers.edu
Adult Infectious Diseases


Anjali Majumdar, MD, FACP
Assistant Professor and Director, Transplant and Oncology Infectious Diseases
Adult Infectious Diseases

Keith Kaye, MD, MPH
Division Chief, Division of Allergy, Immunology and Infectious Diseases and Professor
Emailkk1116@rutgers.edu
Adult Infectious Diseases